INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

76,508 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FD
Fontaine DaniellePrincipal Accounting Officer
NOWServiceNow, Inc.
Option exercise
M—
305 sh
May 7, 2026May 11, 2026
Page 983 of 1913
← PrevNext →
traded May 7, 2026
+4d
SEC Form 4

Evidence

9
TE
Terry Anthony EDirector
NWLNEWELL BRANDS INC.
Option exercise
M—
30.4K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
ZA
Zegna di Monte Rubello AngeloCo-CEO of the ZEGNA brand
ZGNErmenegildo Zegna N.V.
Option exercise
M—
15.6K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,899 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SN
Steele NicolaChief Operating Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$30K
8,137 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
LT
Lee TaeCFO
PLTKPlaytika Holding Corp.
Tax withholding
F$4,501
1,240 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
KM
Klearman MickiDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,200 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
10.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,249 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SA
Swithenbank AuroraEVP, Chief Financial Officer
NMIHNMI Holdings, Inc.
Tax withholding
F—
2,922 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
SE
Spear Catherine EvaDirector
ASAmer Sports, Inc.
Option exercise
M—
7,265 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
4,999 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
2,052 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
GA
Gray James AndyChief Compliance/Risk Officer
ACICAMERICAN COASTAL INSURANCE Corp
Option exercise
M—
8,826 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
PJ
Posadas Laura JDirector
KOPKoppers Holdings Inc.
Option exercise
M—
11 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
MM
Maco MarylouDirector
UDMYUdemy, Inc.
Disposition to issuer
D—
60.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
HC
Hogan Thomas ChristopherEVP/CLO & Corp Secretary
CINFCINCINNATI FINANCIAL CORP
Option exercise
M—
957 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
RR
Rosenthal RobertPresident, Udemy Business
UDMYUdemy, Inc.
Disposition to issuer
D—
485.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SH
Sarrazin HugoDirector, President and CEO
UDMYUdemy, Inc.
Disposition to issuer
D—
47.6K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
12.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
SC
Schiller Mark C.Chief Operating Officer
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
11.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
17.5K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
TA
Tagliabue Gianluca AmbrogioActing Group CEO
ZGNErmenegildo Zegna N.V.
Option exercise
M—
47.3K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
PJ
Posadas Laura JDirector
KOPKoppers Holdings Inc.
Option exercise
M—
11 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
NR
Niebergall RossDirector
VVXV2X, Inc.
Option exercise
M—
838 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

9
BR
Bazarko Anthony R.Chief Commercial Officer
SEERSeer, Inc.
Grant or award
A—
225.0K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
CL
Chiang Pichi LuoSVP, Corporate Controller
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
1,199 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
HH
Hiles HeatherDirector
UDMYUdemy, Inc.
Disposition to issuer
D—
100.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
RG
Robb Andrew GeorgeDirector
DIBS1stdibs.com, Inc.
Grant or award
A—
26.8K sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

9
WC
Wallace CourtneyDirector
KZRKezar Life Sciences, Inc.
Disposition to issuer
D—
5,200 sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

9
VA
Villanueva Rodriguez AlfonsoEVP&Int.Group CEO-VZ Cons.&CTO
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,046
78 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

8
RG
Rubenstein GordonDirector
ACELAccel Entertainment, Inc.
Gift
G—
9,000 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

8
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
230 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

8
WL
Walsh Elizabeth L.Director
CARECarter Bankshares, Inc.
Gift
G—
725 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

8
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
229 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

7
BJ
Buonanno Franck JeanVice-President, Global Sales
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$200
20.0K sh
May 11, 2026May 11, 2026
traded May 11, 2026
+0dSEC Form 4

Evidence

7
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$184K
18.6K sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence

6
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Open-market sale · 10b5-1 plan
SELL$10K
4,000 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

6
AL
Aldema LiorEVP and Chief Business Officer
AUDCAUDIOCODES LTD
Open-market sale · 10b5-1 plan
SELL$23K
2,813 sh
May 8, 2026May 11, 2026
traded May 8, 2026
+3dSEC Form 4

Evidence

6
SA
Schlachet AmirDirector, CEO
GLBEGlobal-E Online Ltd.
Open-market sale · 10b5-1 plan
SELL$201K
6,194 sh
May 7, 2026May 11, 2026
traded May 7, 2026
+4dSEC Form 4

Evidence